[Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm]
R Schneider1, C Schneider2, R Büttner3
1Klinik für Visceral-, Thorax- und Gefäßchirurgie, Philipps-Universität Marburg, Deutschland.
Zentralblatt Fur Chirurgie
|November 6, 2014
Summary
Lynch syndrome, a common hereditary cancer cause, is often missed due to diagnostic uncertainties. Early detection via family history and molecular testing improves patient outcomes and prophylactic options.
Area of Science:
- Oncology
- Genetics
- Hereditary Cancer Syndromes
Background:
- Lynch syndrome accounts for 3-5% of colorectal cancers and is a leading hereditary cause of endometrial cancer.
- It is associated with increased risks for gastric, ovarian, and urinary tract cancers.
- Clinical practice often involves underdiagnosis due to diagnostic uncertainties and lack of awareness.
Purpose of the Study:
- To review and discuss optimized strategies for improved detection of Lynch syndrome.
- To establish a clinical algorithm for diagnostic procedures and surgical options in colorectal cancer patients.
- To highlight the importance of informed decision-making for patients regarding prophylactic surgeries.
Main Methods:
- Ascertainment and evaluation of family history using Amsterdam-II and revised Bethesda criteria.
- Immunohistochemical staining for mismatch-repair genes and BRAF testing for MLH1 loss.
- Microsatellite instability testing, genetic counseling, and mutation analysis when indicated.
Main Results:
- Pathological identification of suspected Lynch syndrome is feasible and straightforward.
- Timely analysis of tumor biopsies is essential for offering extended or prophylactic surgeries.
- Underdiagnosis persists due to limitations in clinical practice, family history assessment, and awareness.
Conclusions:
- Optimized strategies involving family history, molecular testing, and genetic counseling can improve Lynch syndrome detection.
- Multidisciplinary cooperation between gastroenterologists, pathologists, and surgeons is crucial.
- Addressing underdiagnosis is vital to prevent metachronous cancers and ensure at-risk families benefit from screening.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
1000
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.7K
